Frontiers in Oncology

Original Research

Published on 07 Nov 2022

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

in Skin Cancer

Yajun Han
Qinqin Cai
Xiaolin Xie
Shilong Gao
Xiwen Fan

Frontiers in Oncology

doi 10.3389/fonc.2022.1011046

2,312 views
4 citations

Original Research

Published on 07 Nov 2022

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients

in Skin Cancer

Ronen Stoff
Shirly Grynberg
Nethanel Asher
Shachar Laks
Yael Steinberg
Jacob Schachter
Ronnie Shapira-Frommer
Guy Ben-Betzalel

Frontiers in Oncology

doi 10.3389/fonc.2022.1020058

9,542 views
11 citations

Original Research

Published on 02 Nov 2022

A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients

in Skin Cancer

Xinrui Li
Zichao Li
Xiaowei Yi
Xianchun Gao
Zhe Yang
Xingning Huang
Sijie Ma
Tianyuan Ma
Ziyi Deng
Lei Shang

Frontiers in Oncology

doi 10.3389/fonc.2022.929600

1,728 views
1 citation

Original Research

Published on 27 Oct 2022

Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers

in Skin Cancer

Le-Bin Song
Xiang Zhou
Jiao-Chen Luan
Hao-Yang Wang
Xue-Chen Cao
Jia-Wei Lu
Yu-Jie Zheng
Xin-Feng Wu
Yan Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.973579

2,101 views
1 citation

Original Research

Published on 20 Oct 2022

Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis

in Skin Cancer

Ludi Yang
Gaoming Wang
Hanhan Shi
Shichong Jia
Jing Ruan
Ran Cui
Shengfang Ge

Frontiers in Oncology

doi 10.3389/fonc.2022.964902

2,988 views
5 citations

Original Research

Published on 17 Oct 2022

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

in Skin Cancer

Joel Ho
Jane Mattei
Michael Tetzlaff
Michelle D. Williams
Michael A. Davies
Adi Diab
Isabella C. Glitza Oliva
Jennifer McQuade
Sapna P. Patel
Hussein Tawbi

Frontiers in Oncology

doi 10.3389/fonc.2022.1001150

8,534 views
41 citations

Mini Review

Published on 14 Oct 2022

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

in Skin Cancer

Kristen E. Rhodin
Denisse Porras Fimbres
Danielle N. Burner
Shayna Hollander
Margaret H. O’Connor
Georgia M. Beasley

Frontiers in Oncology

doi 10.3389/fonc.2022.1021057

6,855 views
6 citations

Original Research

Published on 13 Oct 2022

Cutaneous verrucous carcinoma: A clinicopathological study of 21 cases with long-term clinical follow-up

in Skin Cancer

Qian Ye
Li Hu
Meng Jia
Li-Jia Deng
Sheng Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.953932

5,327 views
9 citations

Original Research

Published on 12 Oct 2022

A novel melanoma prognostic model based on the ferroptosis-related long non-coding RNA

in Skin Cancer

Yamin Rao
Jinchao Zhu
Haiyan Zheng
Wei Dong
Qingyuan Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.929960

3,474 views
7 citations

Review

Published on 06 Oct 2022

Causes, consequences and clinical significance of aneuploidy across melanoma subtypes

in Skin Cancer

Eva R. Shteinman
James S. Wilmott
Ines Pires da Silva
Georgina V. Long
Richard A. Scolyer
Ismael A. Vergara

Frontiers in Oncology

doi 10.3389/fonc.2022.988691

3,841 views
5 citations

Systematic Review

Published on 30 Sep 2022

The impact of merkel cell polyomavirus positivity on prognosis of merkel cell carcinoma: A systematic review and meta-analysis

in Skin Cancer

Aimin Yang
Wilson Adrian Wijaya
Lei Yang
Yinhai He
Ying Cen
Junjie Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1020805

3,327 views
19 citations

Original Research

Published on 29 Sep 2022

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma

in Skin Cancer

Shaheer Khan
Sapna P. Patel
Alexander N. Shoushtari
Grazia Ambrosini
Serge Cremers
Shing Lee
Lauren Franks
Shahnaz Singh-Kandah
Susana Hernandez
Naomi Sender

Frontiers in Oncology

doi 10.3389/fonc.2022.975643

4,585 views
7 citations

Brief Research Report

Published on 23 Sep 2022

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma

in Skin Cancer

Morgan Homan
Govind Warrier
Christopher D. Lao
Sarah Yentz
Shawna Kraft
Leslie A. Fecher

Frontiers in Oncology

doi 10.3389/fonc.2022.855794

3,147 views
6 citations

Systematic Review

Published on 23 Sep 2022

Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry

in Skin Cancer

Xuan Lei
Yiming Zhang
Lianghao Mao
Pan Jiang
Yumeng Huang
Jia Gu
Ningzheng Tai

Frontiers in Oncology

doi 10.3389/fonc.2022.819051

2,424 views
3 citations

Systematic Review

Published on 14 Sep 2022

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis

in Skin Cancer

Qian Sun
Hongyan Sun
Nan Wu
Yue Hu
Fangqing Zhang
Xianling Cong

Frontiers in Oncology

doi 10.3389/fonc.2022.976224

3,033 views
8 citations

Original Research

Published on 08 Sep 2022

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases

in Skin Cancer

Alexander Z. Wei
Matan Uriel
Agata Porcu
Michael P. Manos
Ann C. Mercurio
Michael M. Caplan
Liam Hulse
Rino S. Seedor
Marta Holovatska
Jasmine Francis

Frontiers in Oncology

doi 10.3389/fonc.2022.961517

7,128 views
7 citations